Nabsys Earns ISO 9001:2015 Certification to Ensure Quality Excellence in Genome Mapping

Nabsys 2.0, LLC Achieves ISO 9001:2015 Certification

Nabsys 2.0, LLC, a leader in electronic genome mapping technology, has accomplished a significant milestone by achieving ISO 9001:2015 certification. This globally recognized standard highlights the company's unwavering commitment to maintaining high-quality management systems, thereby assuring their clients of continuous adherence to rigorous quality standards.

The importance of the ISO 9001:2015 certification cannot be overstated. It affirms Nabsys' capability to consistently deliver products and services that not only satisfy customer expectations but also comply with both regulatory requirements and industry norms. Richard Lussier, Chief Operating Officer at Nabsys, emphasized that this accomplishment speaks volumes about the team's dedication to quality: "This certification reflects our team's unwavering commitment to implementing and upholding a rigorous quality management system. Achieving ISO 9001:2015 status showcases our dedication to excellence and reinforces our customers' trust in us to deliver cutting-edge, reliable electronic genome mapping solutions."

The rigorous certification process reviews various aspects of company operations, emphasizing leadership, process efficiency, risk management, and a customer-centric approach. Continuous improvement is also a significant focus, ensuring that Nabsys remains competitive and relevant in the rapidly evolving field of genomic technology. By aligning with the best practices outlined in ISO 9001:2015, Nabsys confirms its commitment to excellence and its intent to enhance the quality of its products, thereby empowering researchers and scientists globally.

As Nabsys continues to innovate and deliver groundbreaking solutions in genome mapping, this certification reaffirms its role as a key player in this essential domain. The tools and technologies developed at Nabsys enable unprecedented precision and cost-effectiveness in genomic analysis, catering to a diverse clientele ranging from academic institutions to healthcare providers.

Established in Providence, RI, Nabsys is on a mission to revolutionize the understanding of diseases and improve patient outcomes through precise and economical genomic analysis. This requires not just innovation but also excellent quality assurance practices, making the ISO certification a natural fit for the company's operational ethos.

For anyone interested in learning more about Nabsys and its advancements in genomic technology, comprehensive information can be found on their website: www.nabsys.com. Here, you can explore the cutting-edge tools offered by the company, as well as their commitment to quality management and customer satisfaction.

In conclusion, the ISO 9001:2015 certification is not just a badge for Nabsys; it symbolizes the company's ongoing pursuit of quality, efficiency, and excellence in the realm of electronic genome mapping. As they continue to grow and evolve, Nabsys is poised to make significant contributions to scientific advancements in understanding genetic variation and its implications for diagnosing and treating diseases.